Skip to main content
Neurological Research and Practice logoLink to Neurological Research and Practice
. 2025 Nov 17;7(1):92. doi: 10.1186/s42466-025-00432-w

Response to “Acute myeloneuropathy after nitrous oxide use: multimodal diagnostic insights

Julius Nicolai Meißner 1,, Louisa Nitsch 2
PMCID: PMC12625009  PMID: 41250261

Dear Editor,

Thank you for the opportunity to respond to the correspondence entitled “Acute Myeloneuropathy After Nitrous Oxide Use: Multimodal Diagnostic Insights”.

With reference to our article [1] Runzeimer et al. report on diagnostic considerations in nitrous oxide induced neurological damages, presenting a typical case of a 24-year-old male patient showing subacute severe sensorimotor deficits of the lower limbs following recreational nitrous oxide use. Diagnostic workup included laboratory analyses, magnetic resonance imaging of the spinal cord and nerve conduction studies.

The report raises important points of an increasingly relevant neurological disorder. Besides typical imaging and nerve conduction findings, diagnostic pitfalls encountered in functional vitamin B12 deficiency are demonstrated. Especially, serum neurofilament light chain (NfL) levels have not yet been systematically studied in nitrous oxide induced neurological disorders. A relationship of methylmalonic acid levels and NfL levels has recently been demonstrated, possibly linking mitochondrial dysfunction to neuronal damage in nitrous oxide induced myeloneuropathy [2].

However, the specifity of NfL levels is limited. It remains unclear whether it helps distinguish between acute inflammatory polyradiculoneuropathy, or myelopathy of other etiologies, and nitrous oxide-induced disorders [3]. It may be more useful as a parameter for monitoring neurological recovery. Taken together, this report underscores the increasing relevance of the disorder, as it adds to several similar recent case series [4, 5] and a recent survey conducted among practicing neurologists [6].

Finally, we emphasize the call for policy reassessment regarding the accessibility of nitrous oxide.

Yours sincerely,

Julius Meißner and Louisa Nitsch.

Acknowledgements

Not applicable.

Author contributions

All authors drafted and revised the manuscript.

Funding

Open Access funding enabled and organized by Projekt DEAL. The authors declare no funding related to this manuscript.

Data availability

The data supporting the findings of this case report are available from the corresponding author upon reasonable request.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Meißner, J. N., Neuneier, J., Bartzokis, I., Rehm, M., Al-Hayali, A., Müller, M., Paus, S., Limmroth, V., Fink, G. R., Petzold, G. C., & Nitsch, L. (2025). Increase of nitrous oxide-induced neurological disorders - a German multicenter experience. Neurological Research and Practice, 7(1), 3. 10.1186/s42466-024-00361-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wei, J., Liu, Y., & Li, Y. (2025). Association between serum methylmalonic acid (A marker of mitochondrial Dysfunction) and serum neurofilament light chains in a U.S. Population: A Cross-Sectional analysis from NHANES 2013–2014. Brain and Behavior, 15(8), e70775. 10.1002/brb3.70775 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Afzali, A. M., Vosko, M., Reinhardt, N., Zinevych, I., Gmeiner, V., Korn, T., Gasperi, C., Berthele, A., Feneberg, E., & Hemmer, B. (2025). Serum neurofilament light chain predicts disease severity in axonal variants of acute immune neuropathies: A retrospective monocentric cohort study. European Journal of Neurology, 32(1), e16539. 10.1111/ene.16539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Adam, L. C., [Lucas, C.], Grobelny, A., Hahn, K., Audebert, H. J., Krause, P., Franke, C., & Ruprecht, K. (2025). Severe subacute combined degeneration of the spinal cord resulting from nitrous oxide (N2O) abuse: A case series. Neurological Research and Practice, 7(1), 7. 10.1186/s42466-024-00364-x [DOI] [PMC free article] [PubMed]
  • 5.Tshagharyan, A., You, S. J., Grefkes, C., Hattingen, E., Steinbach, J. P., Zeiner, P. S., Hildner, M., & Divé, I. (2025). Neurological disorders caused by recreational use of nitrous oxide-a retrospective study from a German metropolitan area and review of the literature. Neurological Research and Practice, 7(1), 29. 10.1186/s42466-025-00385-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Piel, J. H. A., Adam, L. C., [Lucas Christoph], Möller, L., & Berlit, P. (2025). Nitrous oxide (N2O) recreational use is increasing across Germany - a survey of the German neurological society among practicing neurologists. Neurological Research and Practice, 7(1), 64. 10.1186/s42466-025-00425-9 [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data supporting the findings of this case report are available from the corresponding author upon reasonable request.


Articles from Neurological Research and Practice are provided here courtesy of Deutsche Gesellschaft für Neurologie e.V.

RESOURCES